0001551306-24-000057.txt : 20240403 0001551306-24-000057.hdr.sgml : 20240403 20240403172308 ACCESSION NUMBER: 0001551306-24-000057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240304 FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sturmer Michael E CENTRAL INDEX KEY: 0001837043 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39100 FILM NUMBER: 24820162 MAIL ADDRESS: STREET 1: 48 LEDYARD RD CITY: WEST HARTFORD STATE: CT ZIP: 06117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Progyny, Inc. CENTRAL INDEX KEY: 0001551306 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 272220139 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 212-888-3124 MAIL ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn, Inc. DATE OF NAME CHANGE: 20150318 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn Inc DATE OF NAME CHANGE: 20120601 4 1 wk-form4_1712179367.xml FORM 4 X0508 4 2024-03-04 0 0001551306 Progyny, Inc. PGNY 0001837043 Sturmer Michael E C/O PROGYNY, INC. 1359 BROADWAY, 2ND FL NEW YORK NY 10018 0 1 0 0 PRESIDENT 1 Common Stock 2024-03-04 4 A 0 250000 0 A 390948 D Common Stock 2024-04-01 4 S 0 4515 37.60 D 386433 D Common Stock 2024-04-01 4 S 0 1880 37.60 D 384553 D Stock Option (Right to Buy) 35.48 2024-03-04 4 A 0 600000 0 A 2034-03-03 Common Stock 600000 600000 D Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 25% of the RSUs will vest on March 4, 2025 with the remaining RSUs vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date. Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 31, 2023. Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 25% of the shares subject to the option will vest on March 4, 2025 with the remaining shares subject to the option vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date. /s/ Mark Livingston, Attorney-in-Fact 2024-04-03